Search the Newsreel

Earnings Flash (LEGN) Legend Biotech Corporation Reports Q2 Revenue $387.5M, Vs. FactSet Est of $356.0M

Legend Biotech Corporation (LEGN) reported strong financial results for Q2, with revenues reaching $387.5 million, significantly surpassing the FactSet estimate of $356.0 million. This earnings flash highlights the company's robust revenue performance for the quarter.

JHS Svendgaard turns profitable in Q1FY26 on revenue surge

JHS Svendgaard Laboratories Q1 Results: Net profit turns positive at ₹109 lakh

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History

This article provides comprehensive financial information for Accendra Health, Inc. (ACH), including its stock price, historical data, and recent news. It covers the company's profile as a healthcare solutions provider, its financial performance, earnings trends, and analyst insights. The data indicates significant negative returns …

Legend Biotech (NASDAQ:LEGN) Shares Gap Up After Strong Earnings

Lendlease Global Commercial REIT Secures Tax Ruling on S$120m Perpetual Securities

Dividend 15 Split Corp.’s 13% Yield Looks Attractive, but DFN’s NAV Cushion Is the Number Income Investors Must Watch

Sixth Street Specialty Lending posts investor presentation on debt financing and leverage metrics

Sixth Street Specialty Lending released an investor presentation detailing its debt financing and leverage metrics. The company reported $1.53 billion in commitments under its revolving credit facility and $1.55 billion in unsecured notes. Debt-to-equity increased to 1.27x as of June 30, 2026, with total …

Crexendo’s cloud communications platform reaches 8M users By Investing.com

Crexendo, Inc. announced its cloud communications platform now supports over 8 million users worldwide, adding approximately one million users in eight months. The platform has grown over 370% since Crexendo acquired NetSapiens in June 2021. The company's platform includes CAIRO, an AI receptionist and …

CXDO Looks 8.2% Undervalued on GF Value™

Crexendo Inc (NASDAQ: CXDO) is currently deemed 8.2% undervalued by GuruFocus' GF Value™, with a current price of $6.30 against an intrinsic value of $6.86. The company recently announced its AI-driven UCaaS platform surpassed 8 million global users, reflecting significant growth. While insider selling …

Legend Biotech Q2 Earnings Call Highlights

Key Points Interested in Legend Biotech Corporation Sponsored ADR? Here are five stocks we like better. CARVYKTI sales rose sharply: Worldwide net trade sales increased 50% year over year to approximately $657 million, driven by earlier-line treatment adoption in the U.S. and international expansion …

Earnings call transcript: Legend Biotech tops Q2 2026 estimates as stock rises 5%

Legend Biotech reported stronger-than-expected Q2 2026 results, achieving its first quarter of company-wide profitability with adjusted earnings of $0.16 per share and revenue of $387.5 million, significantly beating analyst estimates. The company's lead CAR-T therapy, CARVYKTI, saw worldwide net trade sales increase 50% year-over-year, …

Crexendo Cloud Platform Adds About 1M Users Worldwide in 8 Months

Crexendo (NASDAQ: CXDO) announced that its AI-enhanced UCaaS cloud communications platform now supports over 8 million users worldwide, an increase of approximately one million users since late 2025. The platform's user base has grown over 370% since the June 2021 acquisition of NetSapiens. The …

Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The CEO who helped guide development of the top-selling cell therapy for multiple myeloma will take the reins of a young startup …

Legend Biotech (NASDAQ: LEGN) surges on CARVYKTI growth and Q2 2026 profitability

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

Baird has downgraded Accendra Health (ACH) from an "Outperform" rating to "Neutral" and significantly lowered its price target from $6 to $1.50. This change in rating and price target follows other recent analyst adjustments, indicating a more cautious outlook for the company. Accendra Health …

Legend Biotech stock rises 5% on earnings and revenue beat

Pipette dropping liquid into a test tube ©Adobe Stock Images Legend Biotech Corporation (NASDAQ:LEGN) shares gained 5.5% in pre-market trading on Tuesday after the pharmaceutical company delivered better-than-expected second-quarter earnings and revenue, supported by continued growth in CARVYKTI sales. Adjusted earnings came in at …

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

Legend Biotech USA Inc. CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 50% versus second quarter of 2025 to approximately $657 million Expanded CARVYKTI® availability to 348 global sites and 19 global markets with the launch of Ireland Achieved first clinical proof-of-concept for LB2501, …

Opendoor’s Q2 Earnings Call: Our Top 5 Analyst Questions

Press Release: CitiTrends Pre-Announces Strong Preliminary Q2 Sales in Advance of Conference Participation and Sets Date for Second Quarter 2026 Earnings Release and Conference Call

CitiTrends (CTRN) has pre-announced strong preliminary second-quarter sales for 2026, ahead of its participation in upcoming investor conferences. The company also set the date for its second-quarter 2026 earnings release and conference call for August 27, 2026. This announcement indicates positive momentum for the …

Morgan Stanley Direct Lending Fund (NYSE:MSDL) Receives Consensus Recommendation of "Hold" from Brokerages

Morgan Stanley Direct Lending Fund (MSDL) has received a consensus "Hold" rating from seven brokerages, with an average 12-month price target of $15.625. Institutional investors have notably increased their holdings in MSDL, while the company reported quarterly EPS in line with estimates at $0.45 …

Blackstone Secured Lending Fund (Dinari Tokenized Stock) (BXSL) Price, MarketCap, Charts and Fundamentals Info

This article provides current price, market capitalization, and fundamental information for Blackstone Secured Lending Fund (Dinari Tokenized Stock) (BXSL), a digital asset. It notes BXSL's market cap of $908.68, a ranking of 13396 in the global cryptocurrency rating, and a 24-hour trading volume of …

TREND GAYRİMENKUL YATIRIM ORTAKLIĞI A.Ş.(TDGYO) Katılım Finansı İlkeleri Bilgi Formu 10 Ağustos 2026

Unlocking Hidden Value: Why Lagenda Properties Is Deeply Undervalued Amid Strategic Restructuring

Be Friends Holding Sets Board Meeting to Review Interim Results and Dividend

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results

This press release from Accendra Health reports their financial results for the second quarter of 2026. Further details on their performance would be contained within the full report.

How (IRT) Movements Inform Risk Allocation Models

This article analyzes Independence Realty Trust Inc. (NYSE: IRT) movements, indicating a neutral sentiment across all time horizons and supporting a wait-and-see approach due to a mid-channel oscillation pattern. It highlights an exceptional 20.0:1 risk-reward setup targeting a 6.1% gain versus 0.3% risk. The …

5 Insightful Analyst Questions From Sixth Street Specialty Lending’s Q2 Earnings Call

Sixth Street Specialty Lending (TSLX) reported Q2 results with a revenue decline but beat analyst expectations. Management highlighted increased repayment activity and stable credit quality. Key analyst questions focused on portfolio turnover, the Structured Credit Partners JV's ramp and yield, pipeline activity translating to …

Earnings Flash (LEGN) Legend Biotech Corporation Posts Q2 Adjusted Net Income $0.16 per Share

Legend Biotech Corporation reported an adjusted net income of $0.16 per share for the second quarter of 2026. This financial announcement was made on August 11, 2026, and also included a reported Q2 revenue of $387.5 million, surpassing FactSet's estimate of $356.0 million. The …

Independent Bank’s Rockland Trust names Brian Kelly director of retail branch banking

Independent Bank's Rockland Trust has promoted Brian Kelly to senior vice president and director of retail branch banking, effective August 12, 2026. In his new role, Kelly will be responsible for leading the bank's retail branch network. He joined Rockland Trust in 2014 and …

Baird downgrades Accendra Health stock rating on weak results

Baird downgraded Accendra Health Inc. (NYSE:ACH) from Outperform to Neutral and cut its price target due to weak results and internal issues. The firm cited unreliable guidance, impending competitive bidding, and the company's micro-cap status with an active at-the-market offering program and poison pill. …

Morgan Stanley Direct Lending Fund (MSDL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Morgan Stanley Direct Lending Fund (MSDL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.5 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

BIOEN Hisse Yorumları (BIOTREND CEVRE VE ENERJI Güncel Yorumlar)

Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates

Carlyle Secured Lending Inc (CGBD) Earnings Forecast: Future EPS & Revenue Growth Estimates

ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6

Baird has downgraded Accendra Health Inc. to a Neutral rating from its previous Outperform rating. Concurrently, the investment firm significantly reduced its target price for Accendra Health Inc. shares to $1.50 from the prior $6.00. This adjustment indicates a revised outlook on the company's …